Objectives: Clinical validation of a computer model assessing the excess cardiac output in fetuses with sacrococcygeal teratoma (SCT). Methods: A computational risk prediction model for SCT was developed. The model accounted for viscosity, sheer stress and the relationship between vessel diameter and flow. Drainage from the SCT (DvSCT) was represented by the differences between superior and inferior caval venous diameters. The additional cardiac output required to perfuse the SCT was represented by the diameter of the umbilical vein (UV) divided by DvSCT and plotted against the gestational age (GA) risk-line modified from the model.
Serial fetal monitoring using ultrasound and Doppler methodology measured the ratio of SCT to estimated fetal weight (EFW) and derived indices of combined cardiac output corrected for EFW (iCCO). These were compared with the high or low estimated risk from the model.
Standard practice at our Centre was to deliver fetuses with uncomplicated SCT at 36 weeks gestation. Delivery at < 32 weeks was therefore used as a surrogate for fetal compromise. Results: Twelve fetuses with SCT were included and monitored serially; outcome was known in 9 fetuses: 6 were delivered prematurely (3 ≤ 32 weeks) and 3 at term. Mean GA at delivery was 33.2 ± 3.6 weeks. One neonate born at 29 weeks demised. UV/DvSCT measurements could be obtained in all fetuses. UV/DvSCT risk at first visit (23.6 ± 2.2 weeks) correlated significantly with GA at delivery (r=0.756; p=0.030). UV/DvSCT ratio correlated with GA delivery < 32 weeks (r=0.393, p=0.011) and the presence/absence of hydrops (r=0.409, p=0.07). No significant correlation was found between iCCO and UV/DvSCT or iCCO and GA at delivery. Conclusions: Measurement of UV/DvSCT is simple and reliable. Unlike iCCO, the UV/DvSCT risk at mid-gestation correlates with GA at delivery. It is a useful adjunct to SCT/EFW ratio as it reflects excess fetal cardiac output required to perfuse the SCT and thus is a useful physiological monitor of fetuses with SCT.
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Objectives TAPSE and MAPSE are indirect indicators of the longitudinal contractility of right and left ventricle. The evolution of TAPSE in hemodynamically healthy fetuses throughout gestation is well known, but there is less information about MAPSE and the relation between both values during fetal life, as well as its evolution in the neonate hemodynamically stable. Our aim was to evaluate TAPSE, MAPSE and TAPSE / MAPSE in hemodynamically normal fetuses throughout gestation and its changes from birth to 30 days postnatal life. Methods: We retrospectively studied 609 different 12-to 39-week pregnancies (media 26,4 wk) with M-Mode echocardiography. The values of TAPSE, MAPSE and TAPSE/MAPSE were determined. The 609 fetuses were cardiologically healthy and of normal weight for gestational age. In the postnatal period, 45 of these patients were studied, with an average of 2 days of age.
Results:
The mean values of TAPSE, MAPSE and TAPSE/MAPSE were respectively: for fetuses <20 wks: 3.3; 1.4 and 2.5; for fetuses 20-24 weeks: 5.1; 3.7 and 1.5; for fetuses 25-29 weeks: 6.1; 4,5 and 1,4; for fetuses 30-34 weeks: 7; 5.3 and 1.4; for fetuses ≥ 35 weeks: 8.4; 6 and 1.5; for newborns: 8,6; 5.3 and 1.7. Conclusions:
